Anebulo Pharmaceuticals, Inc.

ANEB

ANEBAnebulo Pharmaceuticals, Inc. US flag

Other OTC

0.40

USD

-0.03

- -

16.35MMarket Cap

Income Statement (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -
- Operating Expenses	- -	4	7	12	8	8
+ Selling, General & Admin	- -	1	4	6	5	5
+ Research & Development	- -	2	3	6	4	4
+ Other Operating Expense	- -	- -	- -	- -	- -	-1
Operating Income (Loss)	- -	-4	-7	-12	-8	-8
- Non-Operating (Income) Loss	- -	27	- -	- -	- -	- -
+ Interest Expense, Net	- -	- -	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	27	- -	- -	- -	- -
Pretax Income	- -	-30	-7	-12	-8	-8
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	- -	-30	-7	-12	-8	-8
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	- -	-30	-7	-12	-8	-8
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	- -	-30	-7	-12	-8	-8
- Preferred Dividends	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	- -	-30	-7	-12	-8	-8
EBIT	- -	-4	-7	-12	-8	-8
EBITDA	- -	-4	-7	-12	-8	-8
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
EBITA	- -	-4	-7	-12	-8	-8
Gross Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	14	23	25	26	34
Basic EPS, GAAP	- -	-2.22	-0.29	-0.47	-0.32	-0.25
Basic EPS from Cont Ops	- -	-2.22	-0.29	-0.47	-0.32	-0.25
Diluted Weighted Avg Shares	- -	14	23	25	26	34
Diluted EPS, GAAP	- -	-2.22	-0.29	-0.47	-0.32	-0.25
Diluted EPS from Cont Ops	- -	-2.22	-0.29	-0.47	-0.32	-0.25

Balance Sheet (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	3	22	16	12	4	12
+ Cash, Cash Equivalents & STI	3	20	15	11	3	12
+ Cash & Cash Equivalents	3	20	15	11	3	12
+ ST Investments	- -	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	2	1	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -	1	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	1	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	1	- -
Total Assets	3	22	16	12	4	12
+ Payables & Accruals	- -	- -	1	1	- -	- -
+ Accounts Payable	- -	- -	- -	1	- -	- -
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	1	- -	- -
+ ST Debt	- -	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	- -	- -	- -
Total Current Liabilities	- -	- -	1	1	- -	- -
+ LT Debt	- -	- -	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	3	- -	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	3	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	3	- -	- -	- -	- -	- -
Total Liabilities	3	- -	1	1	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	- -	60	61	68	69	86
+ Common Stock	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	- -	60	61	68	69	86
- Treasury Stock	- -	- -	- -	- -	- -	- -
+ Retained Earnings	- -	-39	-45	-57	-65	-74
+ Other Equity	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	- -	21	15	11	4	12
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	- -	21	15	11	4	12
Total Liabilities & Equity	3	22	16	12	4	12
Shares Outstanding	23	23	23	26	26	41
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	- -
Net Debt	-3	-20	-15	-11	-3	-12
Net Debt to Equity	1,649.96	-93.34	-96.56	-106.09	-81.16	-99.74
Tangible Common Equity Ratio	-5.65	98.88	96.71	90.84	93.6	95.98
Current Ratio	13.53	89.61	30.4	10.92	13.46	24.53
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	- -	-30	-7	-12	-8	-8
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -
+ Non-Cash Items	- -	27	- -	1	1	2
+ Stock-Based Compensation	- -	- -	- -	1	1	1
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	27	- -	- -	- -	- -
+ Chg in Non-Cash Work Cap	- -	-1	1	1	-1	- -
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-2	1	1	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	- -	1	-1	- -
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	- -	-5	-5	-10	-8	-6
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	23	- -	7	- -	15
+ Increase in Capital Stock	- -	23	- -	7	- -	15
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	-1	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	22	- -	6	- -	15
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -
Net Changes in Cash	- -	17	-5	-3	-8	9
EBITDA	- -	-4	-7	-12	-8	-8
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Free Cash Flow	- -	-5	-5	-10	-8	-6
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-5	-5	-10	-8	-6
Free Cash Flow per Basic Share	- -	-0.36	-0.23	-0.39	-0.31	-0.19
Price/Free Cash Flow	- -	-19.06	-22.33	-6.09	-8.71	-7.67
Cash Flow to Net Income	- -	0.16	0.8	0.83	0.99	0.75
Capital Expenditures	- -	- -	- -	- -	- -	- -